Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Schizophrenia

  Free Subscription


Articles published in Schizophr Res

Retrieve available abstracts of 514 articles:
HTML format
Text format



Single Articles


    March 2010
  1. BOBES J , Arango C, Garcia-Garcia M, Rejas J, et al
    Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  2. TRINDADE PC , Simonaggio RG, Fernandes LF, Tamai S, et al
    Religiosity and gender differences among Brazilian schizophrenic patients.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  3. NARULA PK , Rehan HS, Unni KE, Gupta N, et al
    Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  4. CONUS P , Lambert M, Cotton S, Bonsack C, et al
    Rate and predictors of service disengagement in an epidemiological first-episode psychosis cohort.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  5. WAFORD RN , Lewine R
    Is perseveration uniquely characteristic of schizophrenia?
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  6. BACHMAN P , Reichenberg A, Rice P, Woolsey M, et al
    Deconstructing processing speed deficits in schizophrenia: Application of a parametric digit symbol coding test.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  7. FAN X , Liu EY, Freudenreich O, Park JH, et al
    Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  8. SCHLAGENHAUF F , Dinges M, Beck A, Wustenberg T, et al
    Switching schizophrenia patients from typical neuroleptics to aripiprazole: Effects on working memory dependent functional activation.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  9. AMAGANE H , Watanabe Y, Kaneko N, Nunokawa A, et al
    Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: A three-stage case-control association study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  10. MODINOS G , Ormel J, Aleman A
    Altered activation and functional connectivity of neural systems supporting cognitive control of emotion in psychosis proneness.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  11. ARBOUR-NICITOPOULOS KP , Faulkner GE, Cohn TA
    Body image in individuals with schizophrenia: Examination of the B-WISE(R) questionnaire.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  12. STRAUSS GP , Jetha SS, Ross SA, Duke LA, et al
    Impaired facial affect labeling and discrimination in patients with deficit syndrome schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  13. SORENSEN HJ , Mortensen EL, Schiffman J, Reinisch JM, et al
    Early developmental milestones and risk of schizophrenia: A 45-year follow-up of the Copenhagen Perinatal Cohort.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  14. JAGER M , Riedel M, Obermeier M, Schennach-Wolff R, et al
    Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  15. OHNUMA T , Shibata N, Baba H, Ohi K, et al
    No association between DAO and schizophrenia in a Japanese patient population: A multicenter replication study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  16. ISMAIL Z , Syms J, Blumberger D, George TP, et al
    Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  17. VERNON MK , Revicki DA, Awad AG, Dirani R, et al
    Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  18. AN SK , Kang JI, Park JY, Kim KR, et al
    Attribution bias in ultra-high risk for psychosis and first-episode schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  19. SCHLOSSER DA , Zinberg JL, Loewy RL, Casey-Cannon S, et al
    Predicting the longitudinal effects of the family environment on prodromal symptoms and functioning in patients at-risk for psychosis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  20. BHOJRAJ TS , Prasad KM, Eack SM, Francis AN, et al
    Do inter-regional gray-matter volumetric correlations reflect altered functional connectivity in high-risk offspring of schizophrenia patients?
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  21. MILLER B , Pihlajamaa J, Haukka J, Cannon M, et al
    Paternal age and mortality in nonaffective psychosis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  22. TAN Y , Luo X, Yang F, Zhang W, et al
    Elevated serum S100B protein in first-episode drug-naive Chinese patients with schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  23. OPLER MG , Harlap S, Ornstein K, Kleinhaus K, et al
    Time-to-pregnancy and risk of schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  24. FATEMI SH
    Co-occurrence of neurodevelopmental genes in etiopathogenesis of autism and schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  25. SCHRETLEN DJ , Vannorsdall TD, Winicki JM, Mushtaq Y, et al
    Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  26. SANTOS JL , Sanchez-Morla EM, Aparicio A, Garcia-Jimenez MA, et al
    P50 gating in deficit and nondeficit schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  27. ALEKSIC B , Kushima I, Ito Y, Nakamura Y, et al
    Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  28. KREMEN WS , Vinogradov S, Poole JH, Schaefer CA, et al
    Cognitive decline in schizophrenia from childhood to midlife: A 33-year longitudinal birth cohort study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  29. MCALLINDON DP , Wilman AH, Purdon SE, Tibbo PG, et al
    Functional magnetic resonance imaging of choice reaction time in chronic schizophrenia and first-degree relatives.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  30. M PRASAD K , N Bamne M, H Shirts B, Goradia D, et al
    Grey matter changes associated with host genetic variation and exposure to Herpes Simplex Virus 1 (HSV1) in first episode schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  31. KIM HS , Shin NY, Choi JS, Jung MH, et al
    Processing of facial configuration in individuals at ultra-high risk for schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


    January 2010
  32. MATHESON SL , Green MJ, Loo C, Carr VJ, et al
    Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: A systematic meta-review.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  33. SMITH GN , Macewan GW, Kopala LC, Ehmann TS, et al
    Prenatal tobacco exposure in first-episode psychosis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  34. BUTLER PD , Schechter I, Revheim N, Silipo G, et al
    Has an important test been overlooked? Closure flexibility in schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  35. ANTICEVIC A , Repovs G, Van Snellenberg JX, Csernansky JG, et al
    Subcortical alignment precision in patients with schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  36. ROTARSKA-JAGIELA A , van de Ven V, Oertel-Knochel V, Uhlhaas PJ, et al
    Resting-state functional network correlates of psychotic symptoms in schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  37. MIYATA J , Yamada M, Namiki C, Hirao K, et al
    Reduced white matter integrity as a neural correlate of social cognition deficits in schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  38. LUOMA S , Hakko H, Marttunen M, Taanila A, et al
    Severe injuries in adolescence predict psychosis: A nested case control study of the Northern Finland 1966 Birth Cohort.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  39. JINDAL RD , Pillai AK, Mahadik SP, Eklund K, et al
    Decreased BDNF in patients with antipsychotic naive first episode schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  40. POIRIER S , Legris G, Tremblay P, Michea R, et al
    Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  41. KIM MA , Tura E, Potkin SG, Fallon JH, et al
    Working memory circuitry in schizophrenia shows widespread cortical inefficiency and compensation.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  42. BELL MD , Johannesen JK, Greig TC, Wexler BE, et al
    Memory profiles in schizophrenia: Categorization validity and stability.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  43. TAKAHASHI M , Hayashi H, Watanabe Y, Sawamura K, et al
    Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  44. STROHMAIER J , Frank J, Wendland JR, Schumacher J, et al
    A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  45. BRESEE LC , Majumdar SR, Patten SB, Johnson JA, et al
    Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  46. KINON BJ , Chen L, Ascher-Svanum H, Stauffer VL, et al
    Challenging the assumption that improvement in functional outcomes is delayed relative to improvement in symptoms in the treatment of schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  47. VAN DEN NOORT M , Bosch P, Mondt K, Lim S, et al
    Progressive volume reduction and its relation to the different stages of schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  48. SEVERANCE EG , Dickerson FB, Halling M, Krivogorsky B, et al
    Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  49. TAKAHASHI T , Wood SJ, Kawasaki Y, Suzuki M, et al
    Lack of progressive gray matter reduction of the superior temporal subregions in chronic schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  50. ELLISON-WRIGHT I , Bullmore E
    Anatomy of bipolar disorder and schizophrenia: A meta-analysis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  51. MONDELLI V , Pariante CM, Navari S, Aas M, et al
    Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  52. ESCARTI MJ , de la Iglesia-Vaya M, Marti-Bonmati L, Robles M, et al
    Increased amygdala and parahippocampal gyrus activation in schizophrenic patients with auditory hallucinations: An fMRI study using independent component analysis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  53. RAN MS , Chen PY, Liao ZG, Chan CL, et al
    Criminal behavior among persons with schizophrenia in rural China.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  54. GLANTZ LA , Gilmore JH, Overstreet DH, Salimi K, et al
    Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  55. LONGENECKER J , Dickinson D, Weinberger DR, Elvevag B, et al
    Cognitive differences between men and women: A comparison of patients with schizophrenia and healthy volunteers.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  56. FISCHER BA , George P
    The investigator and the IRB: A survey of depression and schizophrenia researchers.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  57. MA J , Li DM, Zhang R, Yang XD, et al
    Genetic analysis of glutamate cysteine ligase modifier (GCLM) gene and schizophrenia in Han Chinese.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  58. KOELKEBECK K , Pedersen A, Suslow T, Kueppers KA, et al
    Theory of Mind in first-episode schizophrenia patients: Correlations with cognition and personality traits.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  59. GOULDING SM , Franz L, Bergner E, Compton MT, et al
    Social functioning in urban, predominantly African American, socially disadvantaged patients with first-episode nonaffective psychosis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  60. DE HERT M , Correll CU, Cohen D
    Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  61. CHAN WY , Yang GL, Chia MY, Lau IY, et al
    White matter abnormalities in first-episode schizophrenia: A combined structural MRI and DTI study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  62. STODDARD J , Niendam T, Hendren R, Carter C, et al
    Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  63. PATEL A , Knapp M, Romeo R, Reeder C, et al
    Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  64. FOGELSON DL , Asarnow RA, Sugar CA, Subotnik KL, et al
    Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: The UCLA family study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  65. PAULY K , Seiferth NY, Kellermann T, Ruhrmann S, et al
    The interaction of working memory and emotion in persons clinically at risk for psychosis: An fMRI pilot study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  66. GALAZYN M , Steinberg ML, Gandhi KK, Piper M, et al
    Reasons for smoking among individuals with schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles   


  67. MURPHY ER , Brent BK, Benton M, Pruitt P, et al
    Differential processing of metacognitive evaluation and the neural circuitry of the self and others in schizophrenia: A pilot study.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  68. OHI K , Hashimoto R, Yasuda Y, Yoshida T, et al
    The chitinase 3-like 1 gene and schizophrenia: Evidence from a multi-center case-control study and meta-analysis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  69. TAKAHASHI T , Suzuki M, Zhou SY, Tanino R, et al
    A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  70. TSO IF , Grove TB, Taylor SF
    Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  71. DICKERSON F , Stallings C, Origoni A, Copp C, et al
    Antibodies to measles in individuals with recent onset psychosis.
    Schizophr Res. 2010.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  72. TAYOSHI S , Nakataki M, Sumitani S, Taniguchi K, et al
    GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  73. STORMS G , Elvevag B
    Thinking about semantic concepts in schizophrenia: The more familiar the less deviation.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  74. LARQUET M , Coricelli G, Opolczynski G, Thibaut F, et al
    Impaired decision making in schizophrenia and orbitofrontal cortex lesion patients.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  75. ZHANG XY , Li CB, Li M, Zheng YL, et al
    Smoking initiation and schizophrenia: A replication study in a Chinese Han population.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  76. SIMON JJ , Biller A, Walther S, Roesch-Ely D, et al
    Neural correlates of reward processing in schizophrenia - Relationship to apathy and depression.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  77. PRASAD KM , Goradia D, Eack S, Rajagopalan M, et al
    Cortical surface characteristics among offspring of schizophrenia subjects.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  78. HOUGH D , Gopal S, Vijapurkar U, Lim P, et al
    Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  79. ABBASI SH , Behpournia H, Ghoreshi A, Salehi B, et al
    The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  80. BAKST S , Rabinowitz J, Bromet EJ
    Is poor premorbid functioning a risk factor for suicide attempts in first-admission psychosis?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  81. FAERDEN A , Finset A, Friis S, Agartz I, et al
    Apathy in first episode psychosis patients: One year follow up.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  82. LOPEZ-CASTROMAN J , Gomez DD, Belloso JJ, Fernandez-Navarro P, et al
    Differences in maternal and paternal age between Schizophrenia and other psychiatric disorders.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  83. PALMER BW , Savla GN, Fellows IE, Twamley EW, et al
    Do people with schizophrenia have differential impairment in episodic memory and/or working memory relative to other cognitive abilities?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  84. KRAUSE V , Krastoshevsky O, Coleman MJ, Bodkin JA, et al
    Tailoring the definition of the clinical schizophrenia phenotype in linkage studies.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  85. KOIVUKANGAS J , Tammelin T, Kaakinen M, Maki P, et al
    Physical activity and fitness in adolescents at risk for psychosis within the Northern Finland 1986 Birth Cohort.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  86. VUCHETICH JP , Miranowski SK, Leitten WL, Hill SM, et al
    Deficit schizophrenia does not co-aggregate with high nailfold plexus visibility.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  87. MUESER KT , Lu W, Rosenberg SD, Wolfe R, et al
    The trauma of psychosis: Posttraumatic stress disorder and recent onset psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  88. WILLIAMS LE , Ramachandran VS, Hubbard EM, Braff DL, et al
    Superior size-weight illusion performance in patients with schizophrenia: Evidence for deficits in forward models.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  89. HUSTED JA , Greenwood C, Bassett AS
    RE: Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  90. PANARIELLO F , O'Driscoll L, P de Souza R, Tiwari A, et al
    Age at onset in Canadian Schizophrenia patients: Admixture analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  91. ROSENFIELD PJ , Kleinhaus K, Opler M, Perrin M, et al
    Later paternal age and sex differences in schizophrenia symptoms.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  92. SCHULTZ CC , Koch K, Wagner G, Roebel M, et al
    Reduced cortical thickness in first episode schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  93. RIVEROS R , Manes F, Hurtado E, Escobar M, et al
    Context-sensitive social cognition is impaired in schizophrenic patients and their healthy relatives.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  94. MATTAI A , Chavez A, Greenstein D, Clasen L, et al
    Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  95. TREMEAU F , Antonius D, Cacioppo JT, Ziwich R, et al
    Anticipated, on-line and remembered positive experience in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  96. NUNOKAWA A , Watanabe Y, Kaneko N, Sugai T, et al
    The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: Case-control studies and an updated meta-analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  97. KELLY BD , O'Callaghan E, Waddington JL, Feeney L, et al
    Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in Ireland.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  98. NICOLO JP , Berger GE, Garner BA, Velakoulis D, et al
    The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  99. ALVAREZ-JIMENEZ M , Martinez-Garcia O, Perez-Iglesias R, Ramirez ML, et al
    Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  100. LIN HC , Chen IJ, Chen YH, Lee HC, et al
    Maternal schizophrenia and pregnancy outcome: Does the use of antipsychotics make a difference?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  101. BOTTLENDER R , Strauss A, Moller HJ
    Social disability in schizophrenic, schizoaffective and affective disorders 15years after first admission.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  102. RAPP MA , Schnaider-Beeri M, Purohit DP, Reichenberg A, et al
    Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  103. AZECHI M , Iwase M, Ikezawa K, Takahashi H, et al
    Discriminant analysis in schizophrenia and healthy subjects using prefrontal activation during frontal lobe tasks: A near-infrared spectroscopy.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  104. RAMOS-RIOS R , Arrojo-Romero M, Paz-Silva E, Carballal-Calvo F, et al
    QTc interval in a sample of long-term schizophrenia inpatients.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  105. COHEN AS , Brown LA, Minor KS
    The psychiatric symptomatology of deficit schizophrenia: A meta-analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  106. HUANG SY , Chen HK, Ma KH, Shy MJ, et al
    Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  107. PERLICK DA , Rosenheck RA, Kaczynski R, Swartz MS, et al
    Impact of antipsychotic medication on family burden in schizophrenia: Longitudinal results of CATIE trial.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  108. ROBINSON J , Harris MG, Harrigan SM, Henry LP, et al
    Suicide attempt in first-episode psychosis: A 7.4year follow-up study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  109. CITROME L , Reist C, Palmer L, Montejano LB, et al
    Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  110. SABB FW , van Erp TG, Hardt ME, Dapretto M, et al
    Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  111. SINGH SM , Castellani C, O'Reilly R
    Autism meets schizophrenia via cadherin pathway.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  112. RODRIGUEZ-JIMENEZ R , Bagney A, Martinez-Gras I, Ponce G, et al
    Executive function in schizophrenia: Influence of substance use disorder history.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  113. SIMON AE , Umbricht D
    High remission rates from an initial ultra-high risk state for psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  114. LISING-ENRIQUEZ K , Blank D, Cushing SJ, Bacher IC, et al
    Treatment of co-morbid cocaine dependence in schizophrenia with topiramate.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  115. HERBSMAN T , Nahas Z
    White matter correlates of clinical function in schizophrenia using diffusion tensor imaging.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  116. MORIYA J , Kakeda S, Abe O, Goto N, et al
    Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  117. HOPTMAN MJ , Zuo XN, Butler PD, Javitt DC, et al
    Amplitude of low-frequency oscillations in schizophrenia: A resting state fMRI study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  118. BODEN R , Haenni A, Lindstrom L, Sundstrom J, et al
    Biochemical risk factors for development of obesity in first-episode schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  119. JOSMAN N , Schenirderman AE, Klinger E, Shevil E, et al
    Using virtual reality to evaluate executive functioning among persons with schizophrenia: A validity study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  120. BATES AT , Kiehl KA, Laurens KR, Liddle PF, et al
    Low-frequency EEG oscillations associated with information processing in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  121. MARTINEZ-GRAS I , Rubio G, Del Manzano BA, Rodriguez-Jimenez R, et al
    The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  122. MEDALIA A , Thysen J
    A comparison of insight into clinical symptoms versus insight into neuro-cognitive symptoms in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  123. LEASK SJ , Vermunt JK, Done DJ, Crow TJ, et al
    Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  124. CHANG WC , Pang SL, Chung DW, Chan SS, et al
    Five-year stability of ICD-10 diagnoses among Chinese patients presented with first-episode psychosis in Hong Kong.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  125. BHOJRAJ TS , Francis AN, Rajarethinam R, Eack S, et al
    Verbal fluency deficits and altered lateralization of language brain areas in individuals genetically predisposed to schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  126. COCCHI L , Walterfang M, Testa R, Wood SJ, et al
    Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  127. FOUSSIAS G , Mann S, Zakzanis KK, van Reekum R, et al
    Motivational deficits as the central link to functioning in schizophrenia: A pilot study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  128. TIDEY JW , Rohsenow DJ
    Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  129. COMPTON MT , Goulding SM, Gordon TL, Weiss PS, et al
    Family-level predictors and correlates of the duration of untreated psychosis in African American first-episode patients.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  130. BEASLEY CL , Honavar M, Everall IP, Cotter D, et al
    Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  131. GALDERISI S , Davidson M, Kahn RS, Mucci A, et al
    Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  132. BOTER H , Peuskens J, Libiger J, Fleischhacker WW, et al
    Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST).
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  133. ANSELMETTI S , Bechi M, Bosia M, Quarticelli C, et al
    'Theory' of mind impairment in patients affected by schizophrenia and in their parents.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  134. LEVIN TT
    Newer conceptualizations of schizophrenia demand a name change.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  135. RILEY B , Kuo PH, Maher BS, Fanous AH, et al
    The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  136. MIRANOWSKI SK , Vuchetich JP
    A reliable digital photomicroscopic method of nailfold plexus visibility assessment in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  137. CRESPO-FACORRO B , Roiz-Santianez R, Perez-Iglesias R, Tordesillas-Gutierrez D, et al
    Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteers.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  138. CALLAGHAN RC , Boire MD, Lazo RG, McKenzie K, et al
    Schizophrenia and the incidence of cardiovascular morbidity: A population-based longitudinal study in Ontario, Canada.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  139. ALLAN CL , Cardno AG, Rijsdijk FV, Kalidindi S, et al
    Twin study of illness history variables in psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  140. LEMOS-GIRALDEZ S , Vallina-Fernandez O, Fernandez-Iglesias P, Vallejo-Seco G, et al
    Symptomatic and functional outcome in youth at ultra-high risk for psychosis: A longitudinal study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  141. DE LA SERNA E , Baeza I, Toro J, Andres S, et al
    Relationship between clinical and neuropsychological characteristics in child and adolescent first degree relatives of subjects with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  142. GARD DE , Fisher M, Garrett C, Genevsky A, et al
    Motivation and its Relationship to Neurocognition, Social Cognition, and Functional Outcome in Schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  143. HIRANO Y , Hirano S, Maekawa T, Obayashi C, et al
    Auditory gating deficit to human voices in schizophrenia: A MEG study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  144. GOULDING SM , Chien VH, Compton MT
    Prevalence and correlates of school drop-out prior to initial treatment of nonaffective psychosis: Further evidence suggesting a need for supported education.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  145. EULER M , Thoma RJ, Gangestad SW, Canive JM, et al
    The Impact of developmental instability on voxel-based morphometry analyses of neuroanatomical abnormalities in Schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  146. LEIFKER FR , Bowie CR, Harvey PD
    Determinants of everyday outcomes in schizophrenia: The influences of cognitive impairment, functional capacity, and symptoms.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  147. TURETSKY BI , Crutchley P, Walker J, Gur RE, et al
    Depth of the olfactory sulcus: A marker of early embryonic disruption in schizophrenia?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  148. OLIVEIRA AM , Menezes PR, Busatto GF, McGuire PK, et al
    Family context and duration of untreated psychosis (DUP): Results from the Sao Paulo Study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  149. PENN DL , Keefe RS, Davis SM, Meyer PS, et al
    The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  150. MONDELLI V , Dazzan P, Hepgul N, Di Forti M, et al
    Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  151. SAMAROO D , Dickerson F, Kasarda DD, Green PH, et al
    Novel immune response to gluten in individuals with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  152. KESHAVAN MS , Dick RM, Diwadkar VA, Montrose DM, et al
    Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: A (1)H spectroscopy study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  153. KURTZ MM , Jeffrey SB, Rose J
    Elementary neurocognitive function, learning potential and everyday life skills in schizophrenia: What is their relationship?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  154. BAKALAR JL , Greenstein DK, Clasen L, Tossell JW, et al
    General absence of abnormal cortical asymmetry in childhood-onset schizophrenia: A longitudinal study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  155. PREMKUMAR P , Fannon D, Kuipers E, Peters ER, et al
    Structural magnetic resonance imaging predictors of responsiveness to cognitive behaviour therapy in psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  156. STONE JM , Fusar-Poli P
    Abnormal thalamic glutamate and liability to psychosis: State or trait marker?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  157. RAVIZZA SM , Moua KC, Long D, Carter CS, et al
    The impact of context processing deficits on task-switching performance in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  158. BOBES J , Ciudad A, Alvarez E, San L, et al
    Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remission.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  159. SHEN YC , Liao DL, Chen JY, Wang YC, et al
    Resequencing and association study of vesicular glutamate transporter 1 gene (VGLUT1) with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  160. KIEFER M , Martens U, Weisbrod M, Hermle L, et al
    Increased unconscious semantic activation in schizophrenia patients with formal thought disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  161. BAUER D , Haroutunian V, Meador-Woodruff JH, McCullumsmith RE, et al
    Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  162. CHOI J , Medalia A
    Intrinsic motivation and learning in a schizophrenia spectrum sample.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  163. HADDOCK G , Cross Z, Beardmore R, Tarrier N, et al
    Assessing illicit substance use in schizophrenia: The relationship between self report and detection by hair analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  164. WANG Y , Cui J, Chan RC, Deng Y, et al
    Meta-analysis of prospective memory in schizophrenia: Nature, extent, and correlates.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  165. MITELMAN SA , Nikiforova YK, Canfield EL, Hazlett EA, et al
    A longitudinal study of the corpus callosum in chronic schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  166. MCKEE SA , Weinberger AH, Harrison EL, Coppola S, et al
    Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: A preliminary study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  167. GARD DE , Kring AM
    Emotion in the daily lives of schizophrenia patients: Context matters.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  168. BUSHE CJ , Bradley AJ, Wildgust HJ, Hodgson RE, et al
    Schizophrenia and breast cancer incidence A systematic review of clinical studies.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  169. BUCHSBAUM MS , Haznedar M, Newmark RE, Chu KW, et al
    FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  170. SCHOBEL SA , Kelly MA, Corcoran CM, Van Heertum K, et al
    Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  171. GSCHWANDTNER U , Zimmermann R, Pflueger MO, Riecher-Rossler A, et al
    Negative symptoms in neuroleptic-naive patients with first-episode psychosis correlate with QEEG parameters.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  172. MANE A , Falcon C, Mateos JJ, Fernandez-Egea E, et al
    Progressive gray matter changes in first episode schizophrenia: A 4-year longitudinal magnetic resonance study using VBM.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  173. TORREY EF , Buka S, Cannon TD, Goldstein JM, et al
    Paternal age as a risk factor for schizophrenia: How important is it?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  174. ZAI CC , Tiwari AK, King N, De Luca V, et al
    Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  175. VERCAMMEN A , Knegtering H, Bruggeman R, Westenbroek HM, et al
    Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: A randomized controlled trial.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  176. HELLDIN L , Kane JM, Hjarthag F, Norlander T, et al
    The importance of cross-sectional remission in schizophrenia for long-term outcome: A clinical prospective study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  177. FARIDI K , Pawliuk N, King S, Joober R, et al
    Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  178. SHEN YC , Liao DL, Chen JY, Wang YC, et al
    Exomic sequencing of the glutamate receptor, ionotropic, N-methyl-d-aspartate 3A gene (GRIN3A) reveals no association with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  179. RABIN RA , Sacco KA, George TP
    Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: Effects of smoking status.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  180. SACCHETTI E , Galluzzo A, Valsecchi P, Romeo F, et al
    Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
    Schizophr Res. 2009;113:112-21.
    PubMed     Text format     Related articles    Abstract available


  181. CHEN L , Ascher-Svanum H, Stauffer V, Kinon BJ, et al
    Optimal thresholds of early response to atypical antipsychotics: application of signal detection methods.
    Schizophr Res. 2009;113:34-40.
    PubMed     Text format     Related articles    Abstract available


  182. CARRIZO E , Fernandez V, Connell L, Sandia I, et al
    Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Schizophr Res. 2009;113:19-26.
    PubMed     Text format     Related articles    Abstract available


  183. MONTAGNE-LARMURIER A , Etard O, Razafimandimby A, Morello R, et al
    Two-day treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: a 6 month follow-up pilot study.
    Schizophr Res. 2009;113:77-83.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  184. HAO Y , Yan Q, Liu H, Xu L, et al
    Schizophrenia patients and their healthy siblings share disruption of white matter integrity in the left prefrontal cortex and the hippocampus but not the anterior cingulate cortex.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  185. BRODEUR MB , Pelletier M, Lepage M
    Memory for everyday actions in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  186. IRVIN MR , Wiener HW, Perry RP, Savage RM, et al
    Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  187. COTTON SM , Lambert M, Schimmelmann BG, Foley DL, et al
    Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  188. BENEDETTI F , Bernasconi A, Bosia M, Cavallaro R, et al
    Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  189. RASTOGI A , Zai C, Likhodi O, Kennedy JL, et al
    Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  190. BRENNER CA , Kieffaber PD, Clementz BA, Johannesen JK, et al
    Event-related potential abnormalities in schizophrenia: A failure to "gate in" salient information?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  191. VENTURA J , Hellemann GS, Thames AD, Koellner V, et al
    Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  192. STARING AB , Van der Gaag M, Van den Berge M, Duivenvoorden HJ, et al
    Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  193. MINATOGAWA-CHANG TM , Schaufelberger MS, Ayres AM, Duran FL, et al
    Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: A population-based study of first-episode psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  194. BARTZOKIS G , Lu PH, Stewart SB, Oluwadara B, et al
    In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  195. MITELMAN SA , Canfield EL, Chu KW, Brickman AM, et al
    Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  196. POTVIN S , Blanchet P, Stip E
    Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: A meta-analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  197. EDLINGER M , Hofer A, Rettenbacher MA, Baumgartner S, et al
    Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  198. KANAZAWA T , Glatt SJ, Faraone SV, Hwu HG, et al
    Family-based association study of SELENBP1 in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  199. FULZELE S , Pillai A
    Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  200. VAN RIJN S , Aleman A, De Sonneville L, Swaab H, et al
    Cognitive mechanisms underlying disorganization of thought in a genetic syndrome (47,XXY).
    Schizophr Res. 2009;112.
    PubMed     Text format     Related articles    Abstract available


  201. RUSCH N , Todd AR, Bodenhausen GV, Weiden PJ, et al
    Implicit versus explicit attitudes toward psychiatric medication: Implications for insight and treatment adherence.
    Schizophr Res. 2009;112.
    PubMed     Text format     Related articles    Abstract available


  202. FANNON D , Hayward P, Thompson N, Green N, et al
    The self or the voice? Relative contributions of self-esteem and voice appraisal in persistent auditory hallucinations.
    Schizophr Res. 2009;112.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  203. JINDAL RD , Keshavan MS, Eklund K, Stevens A, et al
    Beat-to-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  204. PRETI A , Meneghelli A, Pisano A, Cocchi A, et al
    Risk of suicide and suicidal ideation in psychosis: Results from an Italian multi-modal pilot program on early intervention in psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  205. KLEJBOR I , Kucinski A, Wersinger SR, Corso T, et al
    Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  206. SCHENNACH-WOLFF R , Jager M, Seemuller F, Obermeier M, et al
    Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  207. FRISHER M , Crome I, Martino O, Croft P, et al
    Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  208. CANUSO CM , Bossie CA, Turkoz I, Alphs L, et al
    Paliperidone extended-release for schizophrenia: Effects on symptoms and functioning in acutely ill patients with negative symptoms.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  209. GUILLEM F , Satterthwaite J, Pampoulova T, Stip E, et al
    Relationship between psychotic and obsessive compulsive symptoms in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  210. BORGWARDT SJ , Riecher-Rossler A, Smieskova R, McGuire PK, et al
    Superior temporal gray and white matter changes in schizophrenia or antipsychotic related effects?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  211. HATTA K , Sato K, Hamakawa H, Takebayashi H, et al
    Effectiveness of second-generation antipsychotics with acute-phase schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  212. YAMADA AM , Barrio C, Harding CM, Webster D, et al
    Cultural themes associated with pathways to initial use of psychiatric services in a tri-ethnic community sample of adults with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  213. BEHERE RV , Venkatasubramanian G, Arasappa R, Reddy N, et al
    Effect of risperidone on emotion recognition deficits in antipsychotic-naive schizophrenia: A short-term follow-up study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  214. ROSENHECK RA , Davis VG, Davis SM, Stroup S, et al
    Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  215. JOSHUA N , Gogos A, Rossell S
    Executive functioning in schizophrenia: A thorough examination of performance on the Hayling Sentence Completion Test compared to psychiatric and non-psychiatric controls.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  216. MANNING V , Betteridge S, Wanigaratne S, Best D, et al
    Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  217. ZHANG XY , Chen DC, Xiu MH, Wang F, et al
    The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  218. KOHLER S , van der Werf M, Hart B, Morrison G, et al
    Evidence that better outcome of psychosis in women is reversed with increasing age of onset: A population-based 5-year follow-up study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  219. STARING AB , Mulder CL, Duivenvoorden HJ, De Haan L, et al
    Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  220. TIMONEN MJ , Saari KM, Jokelainen JJ, Meyer-Rochow VB, et al
    Insulin resistance and schizophrenia: Results from the Northern Finland 1966 Birth Cohort.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  221. YOSHIDA T , McCarley RW, Nakamura M, Lee K, et al
    A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  222. BOUTROS NN , Brockhaus-Dumke A, Gjini K, Vedeniapin A, et al
    Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  223. WEINMANN S , Read J, Aderhold V
    Influence of antipsychotics on mortality in schizophrenia: Systematic review.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  224. GARNER B , Berger GE, Nicolo JP, Mackinnon A, et al
    Pituitary volume and early treatment response in drug-naive first-episode psychosis patients.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  225. TAKEI K , Yamasue H, Abe O, Yamada H, et al
    Structural disruption of the dorsal cingulum bundle is associated with impaired Stroop performance in patients with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  226. MILLER CL , Murakami P, Ruczinski I, Ross RG, et al
    Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  227. EACK SM , Pogue-Geile MF, Greeno CG, Keshavan MS, et al
    Evidence of factorial variance of the Mayer-Salovey-Caruso Emotional Intelligence Test across schizophrenia and normative samples.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  228. THEANDER SS , Wetterberg L
    Schizophrenia in Medline 1950-2006: A bibliometric investigation.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  229. MILLER R , Ream G, McCormack J, Gunduz-Bruce H, et al
    A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  230. BORGWARDT SJ , Dickey C, Pol HH, Whitford TJ, et al
    Workshop on defining the significance of progressive brain change in schizophrenia: December 12, 2008 American College of Neuropsychopharmacology (ACNP) all-day satellite, Scottsdale, Arizona The rapporteurs' report.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  231. DICKERSON FB , Stallings CR, Boronow JJ, Origoni AE, et al
    A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  232. LLORCA PM , Lancon C, Lancrenon S, Bayle FJ, et al
    The "Functional Remission of General Schizophrenia" (FROGS) scale: Development and validation of a new questionnaire.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  233. PANTELIS C , Wood SJ, Proffitt TM, Testa R, et al
    Attentional set-shifting ability in first-episode and established schizophrenia: Relationship to working memory.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  234. GOTO N , Yoshimura R, Moriya J, Kakeda S, et al
    Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  235. LYSAKER PH , Dimaggio G, Carcione A, Procacci M, et al
    Metacognition and schizophrenia: The capacity for self-reflectivity as a predictor for prospective assessments of work performance over six months.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  236. LARGE M , Smith G, Nielssen O
    The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: A systematic review and meta-analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  237. BOSE SK , Mackinnon T, Mehta MA, Turkheimer FE, et al
    The effect of ageing on grey and white matter reductions in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  238. HILL SK , Reilly JL, Harris MS, Rosen C, et al
    A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  239. BARLEY K , Dracheva S, Byne W
    Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  240. CHOCHINOV HM , Martens PJ, Prior HJ, Fransoo R, et al
    Does a diagnosis of schizophrenia reduce rates of mammography screening? A Manitoba population-based study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  241. BAEZA I , Graell M, Moreno D, Castro-Fornieles J, et al
    Cannabis use in children and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study).
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  242. WOZNICA AA , Sacco KA, George TP
    Prepulse inhibition deficits in schizophrenia are modified by smoking status.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  243. MARTENS PJ , Chochinov HM, Prior HJ, Fransoo R, et al
    Are cervical cancer screening rates different for women with schizophrenia? A Manitoba population-based study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  244. JOSHUA N , Rossell S
    Configural face processing in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  245. COLLINSON SL , Mackay CE, O J, James AC, et al
    Dichotic listening impairments in early onset schizophrenia are associated with reduced left temporal lobe volume.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  246. ZIERMANS TB , Durston S, Sprong M, Nederveen H, et al
    No evidence for structural brain changes in young adolescents at ultra high risk for psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  247. CUMMINGS TS , Noordsy DL
    Treatment of catatonic schizophrenia with lorazepam and aripiprazole.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  248. GIBBONS AS , Thomas EA, Dean B
    Regional and duration of illness differences in the alteration of NCAM-180 mRNA expression within the cortex of subjects with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  249. COMBS DR , Penn DL, Tiegreen JA, Nelson A, et al
    Stability and generalization of Social Cognition and Interaction Training (SCIT) for schizophrenia: Six-month follow-up results.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  250. TIZON JL , Ferrando J, Artigue J, Parra B, et al
    Neighborhood differences in psychoses: Prevalence of psychotic disorders in two socially-differentiated metropolitan areas of Barcelona.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  251. PARSONS B , Allison DB, Loebel A, Williams K, et al
    Weight effects associated with antipsychotics: a comprehensive database analysis.
    Schizophr Res. 2009;110.
    PubMed     Text format     Related articles    Abstract available


  252. DE LUCA V , Souza RP, Viggiano E, Zai CC, et al
    MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis.
    Schizophr Res. 2009;110.
    PubMed     Text format     Related articles   


  253. KRAKOWSKI M , Czobor P, Citrome L
    Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol.
    Schizophr Res. 2009;110.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  254. SHAPIRO DI , Marenco S, Spoor EH, Egan MF, et al
    The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  255. CARLBORG A , Jokinen J, Nordstrom AL, Jonsson EG, et al
    CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  256. LUSIGNAN FA , Zadra A, Dubuc MJ, Daoust AM, et al
    Dream content in chronically-treated persons with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  257. BAI YM , Chen TT, Yang WS, Chi YC, et al
    Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: A cohort study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  258. PEUPELMANN J , Boettger MK, Ruhland C, Berger S, et al
    Cardio-respiratory coupling indicates suppression of vagal activity in acute schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  259. YOO SY , Yeon S, Choi CH, Kang DH, et al
    Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  260. KAWASHIMA K , Ikeda M, Kishi T, Kitajima T, et al
    BDNF is not associated with schizophrenia: Data from a Japanese population study and meta-analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  261. GHOSE S , Chin R, Gallegos A, Roberts R, et al
    Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  262. BARTON GR , Hodgekins J, Mugford M, Jones PB, et al
    Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  263. SALIZE HJ , McCabe R, Bullenkamp J, Hansson L, et al
    Cost of treatment of schizophrenia in six European countries.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  264. CHIEN IC , Hsu JH, Lin CH, Bih SH, et al
    Prevalence of diabetes in patients with schizophrenia in Taiwan: A population-based National Health Insurance study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  265. PATEL JK , Buckley PF, Woolson S, Hamer RM, et al
    Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  266. CHEN LS , Rice TK, Thompson PA, Barch DM, et al
    Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  267. TAKAHASHI H , Ideno T, Okubo S, Matsui H, et al
    Impact of changing the Japanese term for "schizophrenia" for reasons of stereotypical beliefs of schizophrenia in Japanese youth.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  268. APIQUIAN R , Elena Ulloa R, Herrera-Estrella M, Moreno-Gomez A, et al
    Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  269. WOLTERS HA , Knegtering H, van den Bosch RJ, Wiersma D, et al
    Effects and side effects of antipsychotic treatment in schizophrenia: Pros and cons of available self-rating scales.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  270. LECARDEUR L , Stip E, Giguere M, Blouin G, et al
    Effects of cognitive remediation therapies on psychotic symptoms and cognitive complaints in patients with schizophrenia and related disorders: A randomized study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  271. ZHUBI A , Veldic M, Puri NV, Kadriu B, et al
    An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  272. KREHER DA , Goff D, Kuperberg GR
    Why all the confusion? Experimental task explains discrepant semantic priming effects in schizophrenia under "automatic" conditions: Evidence from Event-Related Potentials.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  273. CITROME L , Yang R, Glue P, Karayal ON, et al
    Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: A post-hoc analysis of 4 fixed-dose randomized clinical trials.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  274. BUCHY L , Malla A, Joober R, Lepage M, et al
    Delusions are associated with low self-reflectiveness in first-episode psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  275. PETERS BD , Schmitz N, Dingemans PM, van Amelsvoort TA, et al
    Preliminary evidence for reduced frontal white matter integrity in subjects at ultra-high-risk for psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  276. GONG YG , Wu CN, Xing QH, Zhao XZ, et al
    A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  277. MIYATA J , Hirao K, Namiki C, Fujiwara H, et al
    Reduced white matter integrity correlated with cortico-subcortical gray matter deficits in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  278. GOLDBERG TE , Kotov R, Lee AT, Gregersen PK, et al
    The serotonin transporter gene and disease modification in psychosis: Evidence for systematic differences in allelic directionality at the 5-HTTLPR locus.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  279. HARLAP S , Perrin MC, Deutsch L, Kleinhaus K, et al
    Schizophrenia and birthplace of paternal and maternal grandfather in the Jerusalem perinatal cohort prospective study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  280. BOLBECKER AR , Mehta CS, Edwards CR, Steinmetz JE, et al
    Eye-blink conditioning deficits indicate temporal processing abnormalities in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  281. TAKAHASHI T , Wood SJ, Yung AR, Phillips LJ, et al
    Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  282. TREUTLEIN J , Muhleisen TW, Frank J, Mattheisen M, et al
    Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  283. RIETSCHEL M , Georgi A, Schmael C, Schirmbeck F, et al
    Premorbid adjustment: A phenotype highlighting a distinction rather than an overlap between schizophrenia and bipolar disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  284. BERGEN SE , Fanous AH, Walsh D, O'Neill FA, et al
    Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features.
    Schizophr Res. 2009;109.
    PubMed     Text format     Related articles    Abstract available


  285. COHEN AS , Iglesias B, Minor KS
    The neurocognitive underpinnings of diminished expressivity in schizotypy: what the voice reveals.
    Schizophr Res. 2009;109.
    PubMed     Text format     Related articles    Abstract available


  286. ROSS CM
    Epigenetics, traffic and firewood.
    Schizophr Res. 2009;109.
    PubMed     Text format     Related articles   


  287. PENN DL , Meyer PS, Evans E, Wirth RJ, et al
    A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations.
    Schizophr Res. 2009;109.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  288. CAWOOD FW , Bartko JJ
    The correlation of alcohol consumption with schizophrenia hospitalizations: 1934 to 2005.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  289. BOR J , Brunelin J, Rivet A, d'Amato T, et al
    Effects of theta burst stimulation on glutamate levels in a patient with negative symptoms of schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  290. OKOCHI T , Ikeda M, Kishi T, Kawashima K, et al
    Meta-analysis of association between genetic variants in COMT and schizophrenia: An update.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  291. KAWASHIMA T , Nakamura M, Bouix S, Kubicki M, et al
    Uncinate fasciculus abnormalities in recent onset schizophrenia and affective psychosis: A diffusion tensor imaging study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  292. TANDON R , Nasrallah HA, Keshavan MS
    Schizophrenia, "just the facts" 4. Clinical features and conceptualization.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  293. MEYER MB , Kurtz MM
    Elementary neurocognitive function, facial affect recognition and social-skills in Schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  294. ANGLIN D , Stanford AD, Harkavy-Friedman JM, Goetz R, et al
    Family history of affective illness in Schizophrenia patients: Symptoms and cognition.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  295. SKELLEY SL , Miranda RA, Ullman MT, Apud JA, et al
    Where words fail, music speaks: Isolated memory processes in a musical patient with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  296. PANDYA A , Larkin GL, Randles R, Beautrais AL, et al
    Epidemiological trends in psychosis-related Emergency Department visits in the United States, 1992-2001.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  297. RAJCHGOT H , Fathalli F, Rajchgot P, Menezes N, et al
    Decreased tooth size in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  298. SZYCIK GR , Munte TF, Dillo W, Mohammadi B, et al
    Audiovisual integration of speech is disturbed in schizophrenia: An fMRI study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  299. BRILL N , Levine SZ, Reichenberg A, Lubin G, et al
    Pathways to functional outcomes in schizophrenia: The role of premorbid functioning, negative symptoms and intelligence.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  300. BACH DR , Herdener M, Grandjean D, Sander D, et al
    Altered lateralisation of emotional prosody processing in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  301. VELTHORST E , Nieman DH, Becker HE, van de Fliert R, et al
    Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  302. BEASLEY CL , Dwork AJ, Rosoklija G, Mann JJ, et al
    Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  303. SACCHETTI E , Galluzzo A, Valsecchi P, Romeo F, et al
    Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  304. YIP SW , Sacco KA, George TP, Potenza MN, et al
    Risk/reward decision-making in schizophrenia: A preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  305. DERKS EM , Verweij KH, Kahn RS, Cahn WC, et al
    The calculation of familial loading in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  306. GUDLOWSKI Y , Ozgurdal S, Witthaus H, Gallinat J, et al
    Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  307. WIENER HW , Klei L, Irvin MD, Perry RT, et al
    Linkage analysis of schizophrenia in African-American families.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  308. RYBAKOWSKI JK , Skibinska M, Kapelski P, Kaczmarek L, et al
    Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  309. ZHU Y , Kalbfleisch T, Brennan MD, Li Y, et al
    A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  310. BAI YM , Chou KH, Lin CP, Chen IY, et al
    White matter abnormalities in schizophrenia patients with tardive dyskinesia: A diffusion tensor image study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  311. NASRALLAH HA
    Meta-analysis trends in schizophrenia over three decades.
    Schizophr Res. 2009;108.
    PubMed     Text format     Related articles   


    February 2009
  312. SMITH RC , Lindenmayer JP, Davis JM, Cornwell J, et al
    Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  313. EGERTON A , McGuire PK, Howes OD
    Functionally defined regions may aid interpretation of striatal dopamine elevation in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  314. CHANDLEY MJ , Miller MN, Kwasigroch CN, Wilson TD, et al
    Increased antibodies for the alpha7 subunit of the nicotinic receptor in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  315. OHI K , Hashimoto R, Yasuda Y, Yoshida T, et al
    Association study of the G72 gene with schizophrenia in a Japanese population: A multicenter study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  316. FAROOQ S , Large M, Nielssen O, Waheed W, et al
    The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: A systematic review and meta analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  317. KUMARI V , Das M, Taylor PJ, Barkataki I, et al
    Neural and behavioural responses to threat in men with a history of serious violence and schizophrenia or antisocial personality disorder.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  318. LYSAKER PH , Vohs JL, Tsai J
    Negative symptoms and concordant impairments in attention in schizophrenia: Associations with social functioning, hope, self-esteem and internalized stigma.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  319. RAFFARD S , Capdevielle D, Boulenger JP, Bayard S, et al
    Is there really a dissociation between consciousness of cognitive deficits and insight into the symptoms of the disease in schizophrenia?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  320. ALLEN AJ , Griss ME, Folley BS, Hawkins KA, et al
    Endophenotypes in schizophrenia: A selective review.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  321. REIMER J , Fink T, Blaker M, Schafer I, et al
    Successful treatment of psychosis with infliximab in a patient with Crohn's disease.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  322. ZHANG J , Chen J, Xu Q, Shen Y, et al
    Does the presenilin 2 gene predispose to schizophrenia?
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  323. BORA E , Yucel M, Pantelis C
    Theory of mind impairment in schizophrenia: Meta-analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  324. LIU Y , Jandacek R, Rider T, Tso P, et al
    Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: Relationship with fatty acid composition.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  325. DICKERSON FB , Stallings CR, Origoni AE, Sullens A, et al
    A double-blind trial of adjunctive allopurinol for schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  326. KARLSGODT KH , Sanz J, van Erp TG, Bearden CE, et al
    Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  327. SCOTT J , Martin G, Bor W, Sawyer M, et al
    The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey.
    Schizophr Res. 2009;107.
    PubMed     Text format     Related articles    Abstract available


  328. KELLY DL , Wehring HJ, Linthicum J, Feldman S, et al
    Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone.
    Schizophr Res. 2009;107.
    PubMed     Text format     Related articles    Abstract available


  329. KERN RS , Green MF, Nuechterlein KH, Keefe RS, et al
    CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al.
    Schizophr Res. 2009;107.
    PubMed     Text format     Related articles   


  330. PEREZ-IGLESIAS R , Mata I, Pelayo-Teran JM, Amado JA, et al
    Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naive population.
    Schizophr Res. 2009;107.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  331. HEINRICHS RW , Ammari N, Miles A, McDermid Vaz S, et al
    Psychopathology and cognition in divergent functional outcomes in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  332. STEPHENS SH , Logel J, Barton A, Franks A, et al
    Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  333. TIIHONEN J , Wahlbeck K, Kiviniemi V
    The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  334. JOHN JP , Burgess PW, Yashavantha BS, Shakeel MK, et al
    Differential relationship of frontal pole and whole brain volumetric measures with age in neuroleptic-naive schizophrenia and healthy subjects.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  335. WOODWARD ND , Waldie B, Rogers B, Tibbo P, et al
    Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  336. UCHIDA H , Graff-Guerrero A, Mulsant BH, Pollock BG, et al
    Long-term stability of measuring D(2) receptors in schizophrenia patients treated with antipsychotics.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  337. CASTRO MN , Vigo DE, Chu EM, Fahrer RD, et al
    Heart rate variability response to mental arithmetic stress is abnormal in first-degree relatives of individuals with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  338. REUTFORS J , Brandt L, Jonsson EG, Ekbom A, et al
    Risk factors for suicide in schizophrenia: Findings from a Swedish population-based case-control study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  339. THOMPSON JL , Kelly M, Kimhy D, Harkavy-Friedman JM, et al
    Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  340. SEEMAN P
    Schizophrenia model of elevated D2(High) receptors: Haloperidol reverses the amphetamine-induced elevation in dopamine D2(High).
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  341. TAKAHASHI T , Wood SJ, Soulsby B, McGorry PD, et al
    Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  342. CHEN YH , Lee HC, Lin HC
    Prevalence and risk of atopic disorders among schizophrenia patients: A nationwide population based study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  343. CIUDAD A , Alvarez E, Bobes J, San L, et al
    Remission in schizophrenia: Results from a 1-year follow-up observational study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  344. FOLSOM DP , Depp C, Palmer BW, Mausbach BT, et al
    Physical and mental health-related quality of life among older people with schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  345. TAKAHASHI T , Suzuki M, Velakoulis D, Lorenzetti V, et al
    Increased pituitary volume in schizophrenia spectrum disorders.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  346. SMITH GN , Wong H, Macewan GW, Kopala LC, et al
    Predictors of starting to smoke cigarettes in patients with first episode psychosis.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  347. CAPDEVIELLE D , Raffard S, Bayard S, Garcia F, et al
    Competence to consent and insight in schizophrenia: Is there an association? A pilot study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  348. FORNITO A , Yucel M, Patti J, Wood SJ, et al
    Mapping grey matter reductions in schizophrenia: An Anatomical Likelihood Estimation analysis of voxel-based morphometry studies.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  349. IKEZAWA K , Iwase M, Ishii R, Azechi M, et al
    Impaired regional hemodynamic response in schizophrenia during multiple prefrontal activation tasks: A two-channel near-infrared spectroscopy study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  350. POLYMEROPOULOS MH , Licamele L, Volpi S, Mack K, et al
    Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  351. JIMENEZ J , Mancini-Marie A, Mendrek A
    The case for not combining men and women in neurocognitive studies for schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles   


  352. BAI YM , Chen JY, Chen TT, Lin CY, et al
    Weight gain with clozapine: 8-year cohort naturalistic study among hospitalized Chinese schizophrenia patients.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  353. JOFFE G , Terevnikov V, Joffe M, Stenberg JH, et al
    Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: A double-blind, randomized, placebo-controlled trial.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  354. FREITAS C , Fregni F, Pascual-Leone A
    Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  355. SUN D , Phillips L, Velakoulis D, Yung A, et al
    Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  356. LEE K , Yoshida T, Kubicki M, Bouix S, et al
    Increased diffusivity in superior temporal gyrus in patients with schizophrenia: A Diffusion Tensor Imaging study.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  357. BROWN AS , Deicken RF, Vinogradov S, Kremen WS, et al
    Prenatal infection and cavum septum pellucidum in adult schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  358. ELLISON-WRIGHT I , Bullmore E
    Meta-analysis of diffusion tensor imaging studies in schizophrenia.
    Schizophr Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  359. ROSENHECK RA , Davis S, Covell N, Essock S, et al
    Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial.
    Schizophr Res. 2009;107:22-9.
    PubMed     Text format     Related articles    Abstract available


  360. VAN DEN OORD EJ , Adkins DE, McClay J, Lieberman J, et al
    A systematic method for estimating individual responses to treatment with antipsychotics in CATIE.
    Schizophr Res. 2009;107:13-21.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  361. PRASAD KM , Sanders R, Sweeney J, Montrose D, et al
    Neurological abnormalities among offspring of persons with schizophrenia: Relation to premorbid psychopathology.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  362. CITROME L , Reist C, Palmer L, Montejano L, et al
    Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  363. HONG X , Chan RC, Zhuang X, Jiang T, et al
    Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  364. GASPAROTTI R , Valsecchi P, Carletti F, Galluzzo A, et al
    Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  365. TAYOSHI S , Sumitani S, Taniguchi K, Shibuya-Tayoshi S, et al
    Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy ((1)H-MRS).
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  366. NIENDAM TA , Berzak J, Cannon TD, Bearden CE, et al
    Obsessive compulsive symptoms in the psychosis prodrome: Correlates of clinical and functional outcome.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  367. SPOLETINI I , Cherubini A, Di Paola M, Banfi G, et al
    Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  368. DE HERT M , Franic T, Vidovic D, Wampers M, et al
    Prevalence of HIV and hepatitis C infection among patients with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  369. DERNTL B , Finkelmeyer A, Toygar TK, Hulsmann A, et al
    Generalized deficit in all core components of empathy in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  370. SIMON AE , Lester H, Tait L, Stip E, et al
    The International Study on General Practitioners and Early Psychosis (IGPS).
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  371. NOVICK D , Haro JM, Suarez D, Vieta E, et al
    Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  372. YAMADA AM , Barrio C, Atuel H, Harding CM, et al
    A retrospective study of delayed receipt of initial psychiatric services in a tri-ethnic community sample of adults with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  373. NOZAKI S , Kato M, Takano H, Ito H, et al
    Regional dopamine synthesis in patients with schizophrenia using L-[beta-(11)C]DOPA PET.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  374. FITZSIMMONS J , Kubicki M, Smith K, Bushell G, et al
    Diffusion tractography of the fornix in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  375. GOLDBERG TE , Burdick KE, McCormack J, Napolitano B, et al
    Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  376. KIRKPATRICK B , Fernandez-Egea E, Garcia-Rizo C, Bernardo M, et al
    Differences in glucose tolerance between deficit and nondeficit schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  377. LYSAKER PH , Davis LW, Bryson GJ, Bell MD, et al
    Effects of cognitive behavioral therapy on work outcomes in vocational rehabilitation for participants with schizophrenia spectrum disorders.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  378. BYERLY MJ , Marcus RN, Tran QV, Eudicone JM, et al
    Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  379. PHILLIPS OR , Nuechterlein KH, Clark KA, Hamilton LS, et al
    Fiber tractography reveals disruption of temporal lobe white matter tracts in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  380. STROUP TS , Lieberman JA, McEvoy JP, Davis SM, et al
    Results of phase 3 of the CATIE schizophrenia trial.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  381. DJUROVIC S , Kahler AK, Kulle B, Jonsson EG, et al
    A possible association between schizophrenia and GRIK3 polymorphisms in a multicenter sample of Scandinavian origin (SCOPE).
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  382. BATKI SL , Meszaros ZS, Strutynski K, Dimmock JA, et al
    Medical comorbidity in patients with schizophrenia and alcohol dependence.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  383. CASPI A , Vishne T, Reichenberg A, Weiser M, et al
    Refractive errors and schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  384. KLEINMAN L , Lieberman J, Dube S, Mohs R, et al
    Development and psychometric performance of the schizophrenia objective functioning instrument: An interviewer administered measure of function.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  385. GROOTENS KP , Vermeeren L, Jan Verkes R, Buitelaar JK, et al
    Psychomotor planning is deficient in recent-onset schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  386. DICKERSON FB , Stallings CR, Boronow JJ, Origoni AE, et al
    Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  387. ROESCH-ELY D , Hornberger E, Weiland S, Hornstein C, et al
    Do sex differences affect prefrontal cortex associated cognition in schizophrenia?
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  388. KURTZ MM , Seltzer JC, Fujimoto M, Shagan DS, et al
    Predictors of change in life skills in schizophrenia after cognitive remediation.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  389. ADOLFO AB , Ahnallen CG, Tidey JW
    Effects of smoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  390. O'BRIEN MP , Zinberg JL, Ho L, Rudd A, et al
    Family problem solving interactions and 6-month symptomatic and functional outcomes in youth at ultra-high risk for psychosis and with recent onset psychotic symptoms: A longitudinal study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  391. DEMILY C , Cavezian C, Desmurget M, Berquand-Merle M, et al
    The game of chess enhances cognitive abilities in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  392. SACCO KA , Creeden C, Reutenauer EL, Vessicchio JC, et al
    Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  393. STRATTA P , Daneluzzo E, Riccardi I, Bustini M, et al
    Metacognitive ability and social functioning are related in persons with schizophrenic disorder.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  394. DE JONG JJ , Hodiamont PP, Van den Stock J, de Gelder B, et al
    Audiovisual emotion recognition in schizophrenia: Reduced integration of facial and vocal affect.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  395. HAWKEN ER , Crookall JM, Reddick D, Millson RC, et al
    Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: A retrospective study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  396. VLADIMIROV VI , Maher BS, Wormley B, O'Neill FA, et al
    The trace amine associated receptor (TAAR6) gene is not associated with schizophrenia in the Irish Case-Control Study of Schizophrenia (ICCSS) sample.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  397. BODEN R , Sundstrom J, Lindstrom E, Lindstrom L, et al
    Association between symptomatic remission and functional outcome in first-episode schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  398. CHEN Y , Norton D, McBain R, Ongur D, et al
    Visual and cognitive processing of face information in schizophrenia: Detection, discrimination and working memory.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  399. TREMEAU F , Antonius D, Cacioppo JT, Ziwich R, et al
    In support of Bleuler: Objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  400. BERTELSEN M , Jeppesen P, Petersen L, Thorup A, et al
    Course of illness in a sample of 265 patients with first-episode psychosis-Five-year follow-up of the Danish OPUS trial.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  401. KALMADY SV , Venkatasubramanian G
    Evidence for positive selection on Protocadherin Y gene in Homo sapiens: Implications for schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  402. CHOI J , Kurtz MM
    A comparison of remediation techniques on the Wisconsin Card Sorting Test in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  403. HORAN WP , Kern RS, Shokat-Fadai K, Sergi MJ, et al
    Social cognitive skills training in schizophrenia: An initial efficacy study of stabilized outpatients.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  404. HANSSENS L , van Winkel R, Wampers M, Van Eyck D, et al
    A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  405. CONDRAY R , Yao JK, Steinhauer SR, van Kammen DP, et al
    Semantic memory in schizophrenia: Association with cell membrane essential fatty acids.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  406. SAPRA M , Vahia IV, Reyes PN, Ramirez P, et al
    Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  407. MUNOZ MANIEGA S , Lymer GK, Bastin ME, Marjoram D, et al
    A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  408. BOSE SK , Turkheimer FE, Howes OD, Mehta MA, et al
    Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  409. ACOSTA FJ , Bosch E, Sarmiento G, Juanes N, et al
    Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS(R)) and its relationship to sociodemographic, clinical and psychopathological variables.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  410. MACHADO DE SOUSA JP , Hallak JE
    Neurocognitive functioning and facial affect recognition in treatment-resistant schizophrenia treated with clozapine.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  411. LAMBERT M , Schimmelmann BG, Schacht A, Karow A, et al
    Long-term patterns of subjective wellbeing in schizophrenia: Cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  412. XIU MH , Chen S, Wang F, Cao LY, et al
    Altered interleukin-3 serum levels in drug-naive and neuroleptic-treated schizophrenic patients.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  413. GORDON RJ , Seamon JG, Pearlson GD
    An fMRI study of neurocognitive functioning in schizophrenia with a mere exposure paradigm.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  414. LECARDEUR L , Briand C, Prouteau A, Lalonde P, et al
    Preserved awareness of their cognitive deficits in patients with schizophrenia: Convergent validity of the SSTICS.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  415. GABALDA MK , Weiss PS, Compton MT
    Frontal release signs among patients with schizophrenia, their first-degree biological relatives, and non-psychiatric controls.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  416. CHEN DC , Qi LY, Xiu MH, Cao LY, et al
    Elevated serum levels of tumor necrosis factor-alpha in clozapine-associated obesity in chronic schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  417. FU CH , Brammer MJ, Yaguez L, Allen P, et al
    Erratum to "Increased superior temporal activation associated with external misattributions of self-generated speech in schizophrenia" [Schizophrenia Research 100 (1-3) 361-363].
    Schizophr Res. 2008;105.
    PubMed     Text format     Related articles   


  418. BELL MD , Zito W, Greig T, Wexler BE, et al
    Neurocognitive enhancement therapy with vocational services: work outcomes at two-year follow-up.
    Schizophr Res. 2008;105.
    PubMed     Text format     Related articles    Abstract available


  419. TAKAHASHI T , Yung AR, Yucel M, Wood SJ, et al
    Prevalence of large cavum septi pellucidi in ultra high-risk individuals and patients with psychotic disorders.
    Schizophr Res. 2008;105.
    PubMed     Text format     Related articles    Abstract available


  420. DANKERT ME , Brensinger CM, Metzger KL, Li C, et al
    Attitudes of patients and family members towards implantable psychiatric medication.
    Schizophr Res. 2008;105.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  421. ADDINGTON J , Addington D
    Outcome after discharge from an early psychosis program.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  422. PORTON B , Delisi LE, Bertisch HC, Ji F, et al
    Telomerase levels in schizophrenia: A preliminary study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  423. KUBICKI M , Styner M, Bouix S, Gerig G, et al
    Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  424. MATEEN FJ , Josephs KA
    TDP-43 is not present in brain tissue of patients with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  425. AUBIN G , Stip E, Gelinas I, Rainville C, et al
    Daily activities, cognition and community functioning in persons with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  426. MELTZER HY , Brennan MD, Woodward ND, Jayathilake K, et al
    Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  427. KANG JI , Kim JJ, Seok JH, Chun JW, et al
    Abnormal brain response during the auditory emotional processing in schizophrenic patients with chronic auditory hallucinations.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  428. ABUBAKER R , Alaerts M, Allman AA, Barnett J, et al
    Summary of the 1st Schizophrenia International Research Society Conference oral sessions, Venice, Italy, June 21-25, 2008: The rapporteur reports.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  429. BALLMAIER M , Schlagenhauf F, Toga AW, Gallinat J, et al
    Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  430. SAETRE P , Agartz I, De Franciscis A, Lundmark P, et al
    Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control sample.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  431. GERRISH A , Williams H, Moskvina V, Owen MJ, et al
    An examination of MUTED as a schizophrenia susceptibility gene.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  432. KOBAYASHI H , Nemoto T, Koshikawa H, Osono Y, et al
    A self-reported instrument for prodromal symptoms of psychosis: Testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  433. CORCORAN CM , Kimhy D, Stanford A, Khan S, et al
    Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  434. RUIZ-VEGUILLA M , Gurpegui M, Luisa Barrigon M, Ferrin M, et al
    Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  435. PENNINGTON K , Dicker P, Hudson L, Cotter DR, et al
    Evidence for reduced neuronal somal size within the insular cortex in schizophrenia, but not in affective disorders.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  436. KEE KS , Horan WP, Salovey P, Kern RS, et al
    Emotional intelligence in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  437. MORROW EM , Kane A, Goff DC, Walsh CA, et al
    Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  438. HOPTMAN MJ , Nierenberg J, Bertisch HC, Catalano D, et al
    A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  439. TEK C , Srihari V, Tek E
    Successful acamprosate treatment of alcohol dependence in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  440. SUZUKI T , Uchida H, Nomura K, Takeuchi H, et al
    Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  441. EDWARDS TL , Wang X, Chen Q, Wormly B, et al
    Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  442. SHIRTS BH , Prasad KM, Pogue-Geile MF, Dickerson F, et al
    Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  443. CHEN Q , Wang X, O'Neill FA, Walsh D, et al
    Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia?
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  444. OHRMANN P , Kugel H, Bauer J, Siegmund A, et al
    Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  445. HO BC , Epping E, Wang K, Andreasen NC, et al
    Basic helix-loop-helix transcription factor NEUROG1 and schizophrenia: Effects on illness susceptibility, MRI brain morphometry and cognitive abilities.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  446. GOFF DC , Cather C, Gottlieb JD, Evins AE, et al
    Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  447. KESHAVAN MS , Tandon R, Boutros NN, Nasrallah HA, et al
    Schizophrenia, "just the facts": What we know in 2008 Part 3: Neurobiology.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  448. LEESON VC , Barnes TR, Hutton SB, Ron MA, et al
    IQ as a predictor of functional outcome in schizophrenia: A longitudinal, four-year study of first-episode psychosis.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  449. KOHLER CG , Martin EA, Milonova M, Wang P, et al
    Dynamic evoked facial expressions of emotions in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  450. JEAN-MARC C , Mylene L, Renee L, Sylvain G, et al
    Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  451. KANE JM , Assuncao-Talbott S, Eudicone JM, Pikalov A, et al
    The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: A pooled analysis of data from the pivotal trials.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  452. DEAN B , Soulby A, Evin GM, Scarr E, et al
    Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  453. KOHLER CG , Martin EA, Stolar N, Barrett FS, et al
    Static posed and evoked facial expressions of emotions in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  454. AKHONDZADEH S , Mohammadi N, Noroozian M, Karamghadiri N, et al
    Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  455. BORGWARDT SJ , McGuire PK, Aston J, Gschwandtner U, et al
    Reductions in frontal, temporal and parietal volume associated with the onset of psychosis.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  456. SMITH MJ , Barch DM, Csernansky JG
    Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  457. HAWKINS KA , Keefe RS, Christensen BK, Addington J, et al
    Neuropsychological course in the prodrome and first episode of psychosis: Findings from the PRIME North America Double Blind Treatment Study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  458. FENG YQ , Zhou ZY, He X, Wang H, et al
    Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  459. SMITH MJ , Barch DM, Wolf TJ, Mamah D, et al
    Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  460. HIRAO K , Miyata J, Fujiwara H, Yamada M, et al
    Theory of mind and frontal lobe pathology in schizophrenia: A voxel-based morphometry study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  461. SHI J , Badner JA, Willour VL, Potash JB, et al
    Further evidence for an association of G72/G30 with schizophrenia in Chinese.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  462. DAUMIT GL , Goff DC, Meyer JM, Davis VG, et al
    Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  463. O'GRADA C , Barry S, McGlade N, Behan C, et al
    Does the ability to sustain attention underlie symptom severity in schizophrenia?
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  464. MARINI A , Spoletini I, Rubino IA, Ciuffa M, et al
    The language of schizophrenia: An analysis of micro and macrolinguistic abilities and their neuropsychological correlates.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  465. HOLLIS C , Groom MJ, Das D, Calton T, et al
    Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD).
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  466. YUNG AR , Nelson B, Stanford C, Simmons MB, et al
    Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


    August 2008
  467. KLEINHAUS K , Harlap S, Perrin MC, Manor O, et al
    Twin pregnancy and the risk of schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  468. HORTON HK , Silverstein SM
    Social cognition as a mediator of cognition and outcome among deaf and hearing people with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  469. MEDALIA A , Thysen J, Freilich B
    Do people with schizophrenia who have objective cognitive impairment identify cognitive deficits on a self report measure?
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  470. SMITH MJ , Cloninger CR, Harms MP, Csernansky JG, et al
    Temperament and character as schizophrenia-related endophenotypes in non-psychotic siblings.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  471. SHI J , Gershon ES, Liu C
    Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  472. NAKAGAMI E , Xie B, Hoe M, Brekke JS, et al
    Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: Testing mediator and moderator effects.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  473. YARLAGADDA A , Helvink B, Chou C, Gladieux K, et al
    Glutamic acid decarboxylase (GAD) antibodies in tardive dyskinesia (TD) as compared to patients with schizophrenia without TD and normal controls.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  474. CHEN Y , Norton D, McBain R
    Can persons with schizophrenia appreciate visual art?
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  475. WANG Y , Chan RC, Hong X, Ma Z, et al
    Prospective memory in schizophrenia: Further clarification of nature of impairment.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  476. MEISENZAHL EM , Koutsouleris N, Bottlender R, Scheuerecker J, et al
    Structural brain alterations at different stages of schizophrenia: A voxel-based morphometric study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  477. BATKI SL , Leontieva L, Dimmock JA, Ploutz-Snyder R, et al
    Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  478. CALABRESE DR , Wang L, Harms MP, Ratnanather JT, et al
    Cingulate gyrus neuroanatomy in schizophrenia subjects and their non-psychotic siblings.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  479. VITA A , Corsini P, Bonomi S, Cesana BM, et al
    Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles   


  480. PALMER CG , Mallery E, Turunen JA, Hsieh HJ, et al
    Effect of Rhesus D incompatibility on schizophrenia depends on offspring sex.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  481. DEAN B , Crossland N, Boer S, Scarr E, et al
    Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  482. LEYBA L , Mayer AR, Gollub RL, Andreasen NC, et al
    Smoking status as a potential confound in the BOLD response of patients with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  483. BAUER D , Gupta D, Harotunian V, Meador-Woodruff JH, et al
    Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  484. MEDA SA , Bhattarai M, Morris NA, Astur RS, et al
    An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  485. CROW TJ
    Craddock & Owen vs Kraepelin: 85 years late, mesmerised by "polygenes".
    Schizophr Res. 2008;103.
    PubMed     Text format     Related articles    Abstract available


  486. BOUTROS N
    Lack of blinding in gating studies.
    Schizophr Res. 2008;103.
    PubMed     Text format     Related articles   


  487. KIRKPATRICK B , Messias E, LaPorte D
    Schizoid-like features and season of birth in a nonpatient sample.
    Schizophr Res. 2008;103.
    PubMed     Text format     Related articles    Abstract available


    July 2008
  488. MONTE RC , Goulding SM, Compton MT
    Premorbid functioning of patients with first-episode nonaffective psychosis: A comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  489. DOUGHTY OJ , Done DJ, Lawrence VA, Al-Mousawi A, et al
    Semantic memory impairment in schizophrenia - Deficit in storage or access of knowledge?
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  490. FISZDON JM , Choi J, Goulet J, Bell MD, et al
    Temporal relationship between change in cognition and change in functioning in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  491. EBNER F , Tepest R, Dani I, Pfeiffer U, et al
    The hippocampus in families with schizophrenia in relation to obstetric complications.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  492. DIAZ FJ , Velasquez DM, Susce MT, de Leon J, et al
    The association between schizophrenia and smoking: Unexplained by either the illness or the prodromal period.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  493. MARTINEZ-GRANADOS B , Brotons O, Martinez-Bisbal MC, Celda B, et al
    Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  494. GUILLEM F , Pampoulova T, Rinaldi M, Stip E, et al
    Temperament and executive dysfunctions in schizophrenia.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  495. LEE BH , Kim YK
    Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls.
    Schizophr Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  496. SCHWAB SG , Wildenauer DB
    Research on causes for schizophrenia: are we close?
    Schizophr Res. 2008;102.
    PubMed     Text format     Related articles   


  497. MCGRATH J
    Hypotheses desert us, while data defend us.
    Schizophr Res. 2008;102.
    PubMed     Text format     Related articles   


  498. MORITZ S , Laroi F
    Differences and similarities in the sensory and cognitive signatures of voice-hearing, intrusions and thoughts.
    Schizophr Res. 2008;102.
    PubMed     Text format     Related articles    Abstract available


  499. DOLLFUS S , Larmurier-Montagne A, Razafimandimby A, Allio G, et al
    Treatment of auditory hallucinations by combining high-frequency repetitive transcranial magnetic stimulation and functional magnetic resonance imaging.
    Schizophr Res. 2008;102.
    PubMed     Text format     Related articles   


  500. OCHOA S , Haro JM, Torres JV, Pinto-Meza A, et al
    What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia Study.
    Schizophr Res. 2008;102.
    PubMed     Text format     Related articles    Abstract available


  501. BARAK Y , Levy T, Achiron A, Aizenberg D, et al
    Breast cancer in women suffering from serious mental illness.
    Schizophr Res. 2008;102.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  502. LEUCHT S , Shamsi SA, Busch R, Kissling W, et al
    Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study.
    Schizophr Res. 2008;101.
    PubMed     Text format     Related articles    Abstract available


  503. WANG F , Xiu MH, Zhou DF, Cao LY, et al
    The CCR5 32-bp deletion allele is rare in a Chinese population.
    Schizophr Res. 2008;101.
    PubMed     Text format     Related articles   


  504. WU N , Zhang X, Sang H, Liu L, et al
    Lack of association of the KPNB3 locus in case-control samples.
    Schizophr Res. 2008;101.
    PubMed     Text format     Related articles   


  505. JASKIW GE , Konicki PE, Fuller MA
    Clozapine: toxicity vs. postmortem redistribution.
    Schizophr Res. 2008;101.
    PubMed     Text format     Related articles   


    March 2008
  506. HUBER CG , Lambert M, Naber D, Schacht A, et al
    Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients.
    Schizophr Res. 2008;100.
    PubMed     Text format     Related articles    Abstract available


  507. THIRTHALLI J , Bharadwaj B, Kulkarni S, Gangadhar BN, et al
    Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations.
    Schizophr Res. 2008;100.
    PubMed     Text format     Related articles   


  508. JIN H , Meyer JM, Mudaliar S, Jeste DV, et al
    Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.
    Schizophr Res. 2008;100.
    PubMed     Text format     Related articles    Abstract available


  509. SWARTZ MS , Wagner HR, Swanson JW, Stroup TS, et al
    The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
    Schizophr Res. 2008;100.
    PubMed     Text format     Related articles    Abstract available


  510. FIALKO L , Garety PA, Kuipers E, Dunn G, et al
    A large-scale validation study of the Medication Adherence Rating Scale (MARS).
    Schizophr Res. 2008;100.
    PubMed     Text format     Related articles    Abstract available


  511. RABINOWITZ J , Levine SZ, Medori R, Oosthuizen P, et al
    Concordance of patient and clinical ratings of symptom severity and change of psychotic illness.
    Schizophr Res. 2008;100.
    PubMed     Text format     Related articles   


  512. KERNS JG , Becker TM
    Communication disturbances, working memory, and emotion in people with elevated disorganized schizotypy.
    Schizophr Res. 2008;100.
    PubMed     Text format     Related articles    Abstract available


  513. MODESTIN J , Wehrli MV, Stephan PL, Agarwalla P, et al
    Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Schizophr Res. 2008;100.
    PubMed     Text format     Related articles    Abstract available


    February 2008

  514. Introduction to the abstracts of the XIVth biennial Winter workshop on schizophrenia and bipolar disorders.
    Schizophr Res. 2008;98 Suppl:1-2.
    PubMed     Text format     Related articles   


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: